Company Announcements

Pricing of US$350,000,000 Notes Offering

Source: RNS
RNS Number : 5818F
Prudential PLC
22 March 2022

Prudential plc announces pricing of US$350,000,000 Notes Offering

Prudential plc ("Prudential" or the "Company") priced an issue of US$350,000,000 3.625% Notes due 24 March 2032 (the "Notes") under its U.S. Registered Shelf Facility on 21 March 2022. The Notes are senior, unsecured obligations of Prudential. The issuance is expected to be completed on 24 March 2022, subject to customary closing conditions.  Application will be made to list the Notes on the New York Stock Exchange.

The Company intends to apply the proceeds from the sale of the Notes towards the repayment of a US$350 million bank loan.

A preliminary prospectus supplement (the "Preliminary Prospectus Supplement") has been filed with the U.S. Securities and Exchange Commission pursuant to Rule 424(b)(3) of the U.S. Securities Act of 1933, as amended. The Preliminary Prospectus Supplement supplements the base prospectus issued by the Company on 11 August 2020 in relation to the Company's U.S. Registered Shelf Facility (the "Prospectus").

Enquiries to:





Simon Kutner
Ping Ping Tan

+44 (0)20 3977 9760
+65 9845 8904

Patrick Bowes
William Elderkin

+44 (0)20 3977 9702
+44 (0)20 3977 9215

About Prudential plc

Prudential plc provides life and health insurance and asset management in Asia and Africa. The business helps people get the most out of life, by making healthcare affordable and accessible and by promoting financial inclusion. Prudential protects people's wealth, helps them grow their assets, and empowers them to save for their goals. The business has more than 18 million life customers and is listed on stock exchanges in London (PRU), Hong Kong (2378), Singapore (K6S) and New York (PUK). Prudential is not affiliated in any manner with Prudential Financial, Inc. a company whose principal place of business is in the United States of America, nor with The Prudential Assurance Company Limited, a subsidiary of M&G plc, a company incorporated in the United Kingdom.


Please note that the information contained in the Prospectus and the Preliminary Prospectus Supplement (together, the "Offering Materials") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Offering Materials) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Offering Materials is not addressed.  Prior to relying on the information contained in the Offering Materials you must ascertain from the Offering Materials whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.